XBiotech Inc. News
Biotech Movers: Lion Biotechnologies, XBiotech, Halozyme
Lion Biotechnologies, XBiotech and Halozyme Therapeutics were among the biotech movers in premarket trading on Friday.
XBiotech No. 2 Executive Resigns, Leaving Struggling Biotech Without Top Operations Chief
XBiotech offered no reason for Thornburg's resignation, but he left two weeks after European regulators issued a preliminary recommendation to reject the application for the company's colon cancer drug Xilonix.
XBiotech Leaves European Meeting 'Disappointed' Over Colon Cancer Drug Rejection
XBiotech's efforts to shade Xilonix's clinical failings amounted to little more than hand waving when it mattered most. European regulators at the oral explanation meeting on Thursday were not fooled.
XBiotech: Four Staph Patients Died in Our Clinical Trial, Nothing to Worry About
XBiotech did its best in a Monday morning press release to explain away the negative study results for an antibody designed to treat Staph infection.
XBiotech Silent as Deadline for European Resubmission of Colon Cancer Drug Passes
The XBiotech drug, Xilonix, had no effect on the size of colon cancer tumors with zero complete or partial responses reported in the phase III study.
Biotech Stock Mailbag: Puma Roars, Relypsa Soars, XBiotech Bombs
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
Trevor Noah Has Many Potential Replacements at 'The Daily Show'
But Comedy Central could also do something really unexpected with its former flagship program.
Musk Reveals New Cybertruck Features That Will Amaze EV Buyers
Tesla is expected to start production of its highly anticipated futuristic truck in 2023.
Disney Gives Beloved Character a Starring Movie Role
A development team led by Seth Rogen is working on a production that centers on a less well-known character with a nonetheless devoted following.
Fed Inflation Gauge Speeds Higher In August, Adding To Rate Hike Bets
The Fed's preferred inflation gauge topped Street forecasts Friday, snuffing out hopes of a near-term change in the central bank's rate hiking plans.